Aurobindo, Hetero, and Vivimed Class Action Settlements in Montana

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to Montana residents.

Montana residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for Montana residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in Montana

Montana residents affected by the $15.2 million Valsartan, Losartan and Irbesartan class action settlement involving Aurobindo, Hetero, and Vivimed should understand their rights under Montana's Unfair Trade Practices Act (MUTPA), which provides additional consumer protections beyond federal regulations. While these pharmaceutical manufacturers don't maintain major corporate facilities in Montana, their generic blood pressure medications were widely distributed through Montana's pharmacy networks, including independent pharmacies serving rural communities. Montana's vast geography and reliance on mail-order pharmacies means many residents may have unknowingly received contaminated medications containing NDMA and other carcinogens. The state's four-year statute of limitations for personal injury claims provides Montana residents adequate time to join qualifying settlements. Montana courts generally favor class action participation over individual lawsuits for pharmaceutical cases, as consolidation ensures more efficient resolution and better compensation for affected consumers across the state's 56 counties.

How does Montana's rural pharmacy distribution affect my eligibility for the Aurobindo, Hetero, and Vivimed settlement?

Montana residents who received contaminated Valsartan, Losartan, or Irbesartan through rural pharmacies, mail-order services, or tribal health facilities are eligible for the $15.2 million settlement. The widespread distribution network means many Montana patients received these medications regardless of their geographic location within the state.

Can Montana residents file claims if they purchased these medications through tribal health services?

Yes, Montana residents who obtained Valsartan, Losartan, or Irbesartan through Indian Health Service facilities or tribal pharmacies are eligible to participate in the class action settlement. Tribal pharmacy purchases are treated equally to commercial pharmacy purchases for settlement purposes.

What documentation do Montana residents need for Aurobindo, Hetero, and Vivimed claims?

Montana claimants need pharmacy records showing purchases of the affected medications between the specified dates, along with any medical records demonstrating use of these blood pressure medications. Montana's electronic prescription monitoring system can help verify medication history if original receipts are unavailable.

Tips for Montana Residents Filing Aurobindo, Hetero, and Vivimed Claims

Montana residents filing Aurobindo, Hetero, and Vivimed claims should gather all pharmacy records from both retail and mail-order sources, as many rural Montana residents use multiple pharmacy services. Contact your healthcare provider for complete medication histories, especially if you've used Indian Health Service or VA facilities. File claims promptly despite Montana's generous statute of limitations, as settlement funds are distributed on a first-come basis. Keep copies of all medical records related to blood pressure treatment, as future health monitoring may be covered. Consider consulting with Montana attorneys familiar with pharmaceutical class actions, particularly those experienced with the state's unique rural healthcare delivery challenges.

More Montana Resources